Coherus BLA Filing for Adalimumab Biosimilar Candidate Accepted by FDA for Review

NEXT STORY
AREV’s Nanotech initiates early-stage antiviral photochemistry derivation discovery program for pandemic viral pathogens
PREV STORY
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TYME Announces Abstracts Selected for Presentation at the European Society of Medical Oncology Congress 2019

author_avatar
NASDAQ Market News

Innate Pharma highlights next generation of cancer immunotherapies at the American Association of Cancer Research (AACR) 2019 annual meeting

author_avatar
NASDAQ Market News

Translate Bio Announces Proposed Public Offering of Common Stock

author_avatar
NASDAQ Market News